Protalix Biotherapeutics Inc (PLX AMEX) stock market data APIs
$2.7693
-0.13(-4.7%)
as of September 14, 2026
Try our APIs with
free plan!
Protalix Biotherapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.
Prev. Close
2.7693
Open
2.6411
High
2.7729
Low
2.6247
52 wk Range
1.6-3.19
Market Cap
213 M
P/E Ratio
11.4783
Shares Outstanding
80 572 K
Revenue
80 619 K
EPS
0.05
Beta
0.02
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Protalix Biotherapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Protalix Biotherapeutics Inc data using free add-ons & libraries
Get Protalix Biotherapeutics Inc Fundamental Data
Protalix Biotherapeutics Inc Fundamental data includes:
- Net Revenue: 80 619 K
- EBITDA: 24 860 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Protalix Biotherapeutics Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-12
- EPS/Forecast: -0.01
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Protalix Biotherapeutics Inc News
New
Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
CARMIEL, Israel, Sept. 8, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercializatio...
Protalix (PLX) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Investor Relations - Mike Moyer President and Chief Executive Officer - Dror Bashan Senior Vice Presi...
Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary
Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Market Positioning Our analysts just identified a stock with the potential to be the next Nvidia. Tell u...
Here are the major earnings before the open Wednesday
Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/...
Get Protalix Biotherapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
